Flinders University

Vaccination

Closing in on COVID-19 vaccine

South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 ...

Sleep disorders

Relief for people who struggle with CPAP masks

A trial of a simple yet effective surgery has led Australian experts to promote it as an option to specialists around the world for managing difficult obstructive sleep apnoea (OSA) cases.

Sleep disorders

Researchers release global sleep apnoea study

The largest sleep study ever undertaken has found that the leading therapy for obstructive sleep apnea (OSA), Continuous Positive Airway Pressure (CPAP), does not reduce recurrent strokes and heart attacks in people with ...

Genetics

Vaccine blood clotting could be result of genetics

The rare blood clot side-effect associated with some COVID-19 vaccines could be the result of genetics, new research has found, paving the way for a potential genetic screening test.

Diseases, Conditions, Syndromes

Loss of smell sense first sign of COVID-19

Medical experts in countries hit by COVID-19 are reporting the first tell-tale signs of the virus may be in an unexpected loss of smell.

Sleep disorders

Sick of CPAP? New insights into sleep apnea diagnosis

A new approach to measure the common sleep related breathing disorder, obstructive sleep apnea (OSA), estimates that 20% of adults or approximately 1 billion people globally have moderate to severe sleep apnea which can lead ...

Alzheimer's disease & dementia

New biomarker for dementia diagnosis

Medical researchers in the UK and Australia have identified a new marker which could support the search for novel preventative and therapeutic treatments for dementia.

page 2 from 40